All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | TCR Clone | Host Species | Epitope | Allele | Vector Type | Inquiry & Datasheet |
TCR-YF122 | Human anti-EBNA-3 T cell receptor (CF34), pCDTCR1 | EBV | CF34 | Human | FLRGRAYGL | HLA-B8 | Lentiviral vector | |
TCR-YF123 | Human anti-EBNA-3 T cell receptor (LC13), pCDTCR1 | EBV | LC13 | Human | FLRGRAYGL | HLA-B8 | Lentiviral vector | |
TCR-YF124 | Human anti-EBNA-3 T cell receptor (LC13 A95), pCDTCR1 | EBV | LC13 A95 | Human | FLRGRAYGL | HLA-B*08:01 | Lentiviral vector | |
TCR-YF125 | Human anti-EBNA-3 T cell receptor (LC13 E105), pCDTCR1 | EBV | LC13 E105 | Human | FLRGRAYGL | HLA-B*08:01 | Lentiviral vector | |
TCR-YF127 | Human anti-EBNA-3 T cell receptor (LC13 G28), pCDTCR1 | EBV | LC13 G28 | Human | FLRGRAYGL | HLA-B*08:01 | Lentiviral vector | |
TCR-YF128 | Human anti-EBNA-3 T cell receptor (LC13 G96), pCDTCR1 | EBV | LC13 G96 | Human | FLRGRAYGL | HLA-B*08:01 | Lentiviral vector | |
TCR-YF129 | Human anti-EBNA-3 T cell receptor (LC13 H48), pCDTCR1 | EBV | LC13 H48 | Human | FLRGRAYGL | HLA-B*08:01 | Lentiviral vector | |
TCR-YF130 | Human anti-EBNA-3 T cell receptor (LC13 L96), pCDTCR1 | EBV | LC13 L96 | Human | FLRGRAYGL | HLA-B*08:01 | Lentiviral vector | |
TCR-YF131 | Human anti-EBNA-3 T cell receptor (LC13 N51), pCDTCR1 | EBV | LC13 N51 | Human | FLRGRAYGL | HLA-B*08:01 | Lentiviral vector | |
TCR-YF132 | Human anti-EBNA-3 T cell receptor (LC13 N54), pCDTCR1 | EBV | LC13 N54 | Human | FLRGRAYGL | HLA-B*08:01 | Lentiviral vector | |
TCR-YF133 | Human anti-EBNA-3 T cell receptor (LC13 Q50), pCDTCR1 | EBV | LC13 Q50 | Human | FLRGRAYGL | HLA-B*08:01 | Lentiviral vector | |
TCR-YF134 | Human anti-EBNA-3 T cell receptor (LC13 S25), pCDTCR1 | EBV | LC13 S25 | Human | FLRGRAYGL | HLA-B*08:01 | Lentiviral vector | |
TCR-YF135 | Human anti-EBNA-3 T cell receptor (LC13 S27), pCDTCR1 | EBV | LC13 S27 | Human | FLRGRAYGL | HLA-B*08:01 | Lentiviral vector | |
TCR-YF136 | Human anti-EBNA-3 T cell receptor (LC13 S28), pCDTCR1 | EBV | LC13 S28 | Human | FLRGRAYGL | HLA-B*08:01 | Lentiviral vector | |
TCR-YF137 | Human anti-EBNA-3 T cell receptor (LC13 S31), pCDTCR1 | EBV | LC13 S31 | Human | FLRGRAYGL | HLA-B*08:01 | Lentiviral vector | |
TCR-YF138 | Human anti-EBNA-3 T cell receptor (LC13 S52), pCDTCR1 | EBV | LC13 S52 | Human | FLRGRAYGL | HLA-B*08:01 | Lentiviral vector | |
TCR-YF139 | Human anti-EBNA-3 T cell receptor (LC13 S94), pCDTCR1 | EBV | LC13 S94 | Human | FLRGRAYGL | HLA-B*08:01 | Lentiviral vector | |
TCR-YF140 | Human anti-EBNA-3 T cell receptor (LC13 S95), pCDTCR1 | EBV | LC13 S95 | Human | FLRGRAYGL | HLA-B*08:01 | Lentiviral vector | |
TCR-YF141 | Human anti-EBNA-3 T cell receptor (LC13 S99), pCDTCR1 | EBV | LC13 S99 | Human | FLRGRAYGL | HLA-B*08:01 | Lentiviral vector | |
TCR-YF142 | Human anti-EBNA-3 T cell receptor (LC13 T26), pCDTCR1 | EBV | LC13 T26 | Human | FLRGRAYGL | HLA-B*08:01 | Lentiviral vector |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION